uOttawa Department of Psychiatry, Ottawa, ON, Canada (Sinthuja S, KP); Department of Applied Psychology and Human Development, University of Toronto, Toronto, ON, Canada (DJ); Columbia University Mailman School of Public Health, Department of Epidemiology, New York, NY (Shalini S); uOttawa School of Epidemiology and Public Health, Ottawa, ON, Canada (FLT); Department of Neuroscience, Carleton University, Ottawa, ON, Canada (SDS, PP); CHEO Research Institute, Ottawa, ON, Canada (MS, KP).
Send correspondence to Kathleen Pajer, MD, MPH, CHEO, 401 Smyth Road, Ottawa, ON K1H 8L1, Canada. E-mail: [email protected].
Received 12 February, 2020
Accepted 10 January, 2021
Supported by a grant from the CHEO Psychiatry Associates (CPA) Research Fund, CHEO, Ottawa, Ontario, Canada.
The authors report no conflicts of interest.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal's Web site (www.journaladdictionmedicine.com).
